These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16374375)

  • 1. The use of immunocompromised animals as models for human septic shock.
    Opal SM; Cross AS
    Shock; 2005 Dec; 24 Suppl 1():64-70. PubMed ID: 16374375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
    Stolk RF; van der Poll T; Angus DC; van der Hoeven JG; Pickkers P; Kox M
    Am J Respir Crit Care Med; 2016 Sep; 194(5):550-8. PubMed ID: 27398737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis severe or septic shock: outcome according to immune status and immunodeficiency profile.
    Tolsma V; Schwebel C; Azoulay E; Darmon M; Souweine B; Vesin A; Goldgran-Toledano D; Lugosi M; Jamali S; Cheval C; Adrie C; Kallel H; Descorps-Declere A; Garrouste-Orgeas M; Bouadma L; Timsit JF
    Chest; 2014 Nov; 146(5):1205-1213. PubMed ID: 25033349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor and innate immune responses to bacterial infections.
    Froidevaux C; Roger T; Martin C; Glauser MP; Calandra T
    Crit Care Med; 2001 Jul; 29(7 Suppl):S13-5. PubMed ID: 11445727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic biomarkers for human sepsis and septic shock: insights from immunosuppression.
    Beltrán-García J; Osca-Verdegal R; Romá-Mateo C; Carbonell N; Ferreres J; Rodríguez M; Mulet S; García-López E; Pallardó FV; García-Giménez JL
    Epigenomics; 2020 Apr; 12(7):617-646. PubMed ID: 32396480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil Activation During Septic Shock.
    Stiel L; Meziani F; Helms J
    Shock; 2018 Apr; 49(4):371-384. PubMed ID: 28858142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic Profiles in Children With Septic Shock With or Without Immunoparalysis.
    Snyder A; Jedreski K; Fitch J; Wijeratne S; Wetzel A; Hensley J; Flowers M; Bline K; Hall MW; Muszynski JA
    Front Immunol; 2021; 12():733834. PubMed ID: 34659221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunopathogenesis of sepsis in elderly patients.
    Opal SM; Girard TD; Ely EW
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S504-12. PubMed ID: 16237654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of age on the innate immune response and outcomes after severe sepsis/septic shock in trauma and surgical intensive care unit patients.
    Brakenridge SC; Efron PA; Stortz JA; Ozrazgat-Baslanti T; Ghita G; Wang Z; Bihorac A; Mohr AM; Brumback BA; Moldawer LL; Moore FA
    J Trauma Acute Care Surg; 2018 Aug; 85(2):247-255. PubMed ID: 29613958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock.
    Venet F; Tissot S; Debard AL; Faudot C; Crampé C; Pachot A; Ayala A; Monneret G
    Crit Care Med; 2007 Aug; 35(8):1910-7. PubMed ID: 17568330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis.
    Natanson C; Hoffman WD; Suffredini AF; Eichacker PQ; Danner RL
    Ann Intern Med; 1994 May; 120(9):771-83. PubMed ID: 8147551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin as a drug target.
    Opal SM; Glück T
    Crit Care Med; 2003 Jan; 31(1 Suppl):S57-64. PubMed ID: 12544978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis-induced immunoparalysis: mechanisms, markers, and treatment options.
    Hamers L; Kox M; Pickkers P
    Minerva Anestesiol; 2015 Apr; 81(4):426-39. PubMed ID: 24878876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mouse Models of Sepsis and Septic Shock].
    Korneev KV
    Mol Biol (Mosk); 2019; 53(5):799-814. PubMed ID: 31661479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRAK4 as a molecular target in the amelioration of innate immunity-related endotoxic shock and acute liver injury by chlorogenic acid.
    Park SH; Baek SI; Yun J; Lee S; Yoon DY; Jung JK; Jung SH; Hwang BY; Hong JT; Han SB; Kim Y
    J Immunol; 2015 Feb; 194(3):1122-30. PubMed ID: 25548221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glucocorticoids as adjunctive treatment for sepsis in the modern era.
    Marik PE
    Lancet Respir Med; 2018 Oct; 6(10):793-800. PubMed ID: 30006071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resuscitation bundle compliance in severe sepsis and septic shock: improves survival, is better late than never.
    Coba V; Whitmill M; Mooney R; Horst HM; Brandt MM; Digiovine B; Mlynarek M; McLellan B; Boleski G; Yang J; Conway W; Jordan J;
    J Intensive Care Med; 2011; 26(5):304-13. PubMed ID: 21220270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs).
    Yanai H; Chiba S; Ban T; Nakaima Y; Onoe T; Honda K; Ohdan H; Taniguchi T
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11542-7. PubMed ID: 21709231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sepsis and the septic shock in oncological or other immunocompromised patients--diagnosis, therapy].
    Navrátil M; Tomíska M; Korístek Z; Vorlícek J; Mayer J
    Vnitr Lek; 2010 Jun; 56(6):557-69. PubMed ID: 20681468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Receptors and signal proteins of the innate immune system as new targets in sepsis therapy. Reprogramming of the immune response].
    Holzmann B; Weighardt H; Heidecke CD
    Chirurg; 2003 Jan; 74(1):61-4. PubMed ID: 12552407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.